Ge Healthcare Technologies Stock Today

GEHC Stock   81.49  0.32  0.39%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
GE HealthCare is trading at 81.49 as of the 24th of March 2025, a 0.39% down since the beginning of the trading day. The stock's open price was 81.81. GE HealthCare has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Note, on January 23, 2023, Representative Austin Scott of US Congress acquired under $15k worth of GE HealthCare Techno's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
4th of January 2023
Category
Healthcare
Classification
Health Care
GE HealthCare is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 457.3 M outstanding shares of which 9.24 M shares are currently shorted by private and institutional investors with about 3.52 trading days to cover. More on GE HealthCare Technologies

Moving together with GEHC Stock

  0.81RVP Retractable Technologies Earnings Call This WeekPairCorr
  0.74HIMS Hims Hers Health Buyout TrendPairCorr
  0.68MLSS Milestone Scientific Earnings Call This WeekPairCorr

Moving against GEHC Stock

  0.62VINC Vincerx Pharma Earnings Call This WeekPairCorr
  0.42ELVN Enliven TherapeuticsPairCorr
  0.36SSKN STRATA Skin Sciences Earnings Call TomorrowPairCorr
  0.32HOLX HologicPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

GEHC Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO PresidentPeter Arduini
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ 100 Equal, Nasdaq 100, NASDAQ 100 Pre, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors)
Average Analyst Recommendation
Debt Levels
GE HealthCare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand GE HealthCare's financial leverage. It provides some insight into what part of GE HealthCare's total assets is financed by creditors.
Liquidity
GE HealthCare Technologies currently holds 1.5 B in liabilities. Note, when we think about GE HealthCare's use of debt, we should always consider it together with its cash and equity.

Investments

(868.3 Million)
GE HealthCare Technologies (GEHC) is traded on NASDAQ Exchange in USA. It is located in 500 West Monroe Street, Chicago, IL, United States, 60661 and employs 53,000 people. GE HealthCare is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 37.27 B. GE HealthCare Techno conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 457.3 M outstanding shares of which 9.24 M shares are currently shorted by private and institutional investors with about 3.52 trading days to cover. GE HealthCare generates positive cash flow from operations, but has no cash available
Check GE HealthCare Probability Of Bankruptcy
Ownership Allocation
GE HealthCare Techno secures a total of 457.3 Million outstanding shares. The majority of GE HealthCare Techno outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to purchase positions in GE HealthCare Technologies to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in GE HealthCare Techno. Please pay attention to any change in the institutional holdings of GE HealthCare as this could imply that something significant has changed or is about to change at the company. On January 23, 2023, Representative Austin Scott of US Congress acquired under $15k worth of GE HealthCare Techno's common stock.
Check GEHC Ownership Details

GE HealthCare Historical Income Statement

At present, GE HealthCare's Interest Income is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 530.2 M, whereas Net Interest Income is projected to grow to (479.8 M). View More Fundamentals

GEHC Stock Against Markets

GE HealthCare Corporate Executives

Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.784
Dividend Share
0.125
Earnings Share
4.34
Revenue Per Share
43.14
Quarterly Revenue Growth
0.022
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.